Telehealth options are assumed to provide added benefit to providers and patients alike, but how much do we really know and understand about telemedicine? Listen in to the latest episode of Global Hemophilia Report as our contributors share how telemedicine has potentially benefited and detracted from hemophilia care across different populations as well as what research must still be done on the rise of telehealth in hemophilia care

 

Contributors:

Sativa Rangarajan, Associate Professor of Clinical Haematology 

Michelle Witkop, DNP, FNP-BC 

Dr. Roshni Kulkarni, Professor & Former Director

Michigan State University Centers For Bleeding And Clotting Disorders

Annette von Drygalski, MD, PharmD

 

Senior Advisor:

Donna DiMichele, MD

 

Hosted by:

Patrick James Lynch

Written by:

Simantini Karve, PhD

 

Show Notes:

Presenting Sponsor: Sanofi

 

Subscribe to the Global Hemophilia Report

 

Connect with the Global Hemophilia Report

Global Hemophilia Report on LinkedIn

Global Hemophilia Report on Twitter

Global Hemophilia Report on Facebook

 

Connect with BloodStream Media:

BloodStreamMedia.com

BloodStream on Facebook 

BloodStream on Twitter